A new study is using artificial intelligence to stop the trial-and-error process of prescribing antidepressants to patients. Two-thirds of patients with depression do not respond to their first prescription. Dr. Jay Faber joined CBSN to explain how artificial intelligence tracks brain activity and how patients may benefit.